Cargando…
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
The emergence of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected global public health and economy. Despite the substantial efforts, only few vaccines are currently approved and some are in the different stages of clinical trials...
Autores principales: | Siriwattananon, Konlavat, Manopwisedjaroen, Suwimon, Shanmugaraj, Balamurugan, Rattanapisit, Kaewta, Phumiamorn, Supaporn, Sapsutthipas, Sompong, Trisiriwanich, Sakalin, Prompetchara, Eakachai, Ketloy, Chutitorn, Buranapraditkun, Supranee, Wijagkanalan, Wassana, Tharakhet, Kittipan, Kaewpang, Papatsara, Leetanasaksakul, Kantinan, Kemthong, Taratorn, Suttisan, Nutchanat, Malaivijitnond, Suchinda, Ruxrungtham, Kiat, Thitithanyanont, Arunee, Phoolcharoen, Waranyoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158422/ https://www.ncbi.nlm.nih.gov/pubmed/34054909 http://dx.doi.org/10.3389/fpls.2021.682953 |
Ejemplares similares
-
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
por: Siriwattananon, Konlavat, et al.
Publicado: (2021) -
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
por: Prompetchara, Eakachai, et al.
Publicado: (2021) -
Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies
por: Hanittinan, Oranicha, et al.
Publicado: (2022) -
CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2
por: Laotee, Sedthawut, et al.
Publicado: (2023) -
A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)